{
  "id": 19189185,
  "title": "Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss",
  "url": "https://urgent.news/2026/11/09/ozempic-zepbound-and-other-glp-1-drugs-have-a-possible-risk-of-vision-19189185",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-09T17:52:00.000Z",
  "source": {
    "name": "MarketWatch",
    "slug": "marketwatch",
    "url": "https://www.marketwatch.com/story/ozempic-zepbound-and-other-glp-1-drugs-have-a-possible-risk-of-vision-loss-b3738f36?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}